New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients

被引:191
作者
Sia, IG
Patel, R
机构
[1] Mayo Clin & Mayo Fdn, Div Infect Dis, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA
关键词
D O I
10.1128/CMR.13.1.83-121.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In the past three decades since the inception of human organ transplantation, cytomegalovirus (CMV) has gained increasing clinical import because it is a common pathogen in the immunocompromised transplant recipient. Patients may suffer from severe manifestations of this infection along with the threat of potential fatality. Additionally, the dynamic evolution of immunosuppressive and antiviral agents has brought forth changes in the natural history of CMV infection and disease. Transplant Physicians now face the daunting task of recognizing and managing the changing spectrum of CMV infection and its consequences in the organ recipient. For the microbiology laboratory, the emphasis has been geared toward the development of more sophisticated detection assays, including methods to detect emerging antiviral resistance. The discovery of novel antiviral chemotherapy is an important theme of clinical research. Investigations have also focused on preventative measures for CMV disease in the solid-organ transplant population. In all, while much has been achieved in the overall management of CMV infection, the current understanding of CMV pathogenesis and therapy still leaves much to be learned before success can be claimed.
引用
收藏
页码:83 / +
页数:41
相关论文
共 516 条
[21]  
Bailey T C, 1993, Semin Respir Infect, V8, P225
[22]   QUANTITATIVE-ANALYSIS OF CYTOMEGALOVIRUS VIREMIA IN LUNG-TRANSPLANT RECIPIENTS [J].
BAILEY, TC ;
BULLER, RS ;
ETTINGER, NA ;
TRULOCK, EP ;
GAUDREAULTKEENER, M ;
LANGLOIS, TM ;
FORNOFF, JER ;
COOPER, JD ;
STORCH, GA .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :1006-1010
[23]   FAILURE OF HIGH-DOSE ORAL ACYCLOVIR WITH OR WITHOUT IMMUNE GLOBULIN TO PREVENT PRIMARY CYTOMEGALOVIRUS DISEASE IN RECIPIENTS OF SOLID-ORGAN TRANSPLANTS [J].
BAILEY, TC ;
ETTINGER, NA ;
STORCH, GA ;
TRULOCK, EP ;
HANTO, DW ;
DUNAGAN, WC ;
JENDRISAK, MD ;
MCCULLOUGH, CS ;
KENZORA, JL ;
POWDERLY, WG .
AMERICAN JOURNAL OF MEDICINE, 1993, 95 (03) :273-278
[24]   Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS [J].
Baldanti, F ;
Underwood, MR ;
Stanat, SC ;
Biron, KK ;
Chou, SW ;
Sarasini, A ;
Silini, E ;
Gerna, G .
JOURNAL OF VIROLOGY, 1996, 70 (03) :1390-1395
[25]  
Baldanti F, 1998, ANTIMICROB AGENTS CH, V42, P444
[26]   Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood [J].
Baldanti, F ;
Simoncini, L ;
Sarasini, A ;
Zavattoni, M ;
Grossi, P ;
Revell, MG ;
Gerna, G .
TRANSPLANTATION, 1998, 66 (03) :324-329
[27]  
Bale JF, 1999, ARCH PEDIAT ADOL MED, V153, P75
[28]   A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ORAL ACYCLOVIR FOR THE PREVENTION OF CYTOMEGALO-VIRUS DISEASE IN RECIPIENTS OF RENAL-ALLOGRAFTS [J].
BALFOUR, HH ;
CHACE, BA ;
STAPLETON, JT ;
SIMMONS, RL ;
FRYD, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) :1381-1387
[29]   OBLITERATIVE BRONCHIOLITIS AFTER LUNG AND HEART-LUNG TRANSPLANTATION - AN ANALYSIS OF RISK-FACTORS AND MANAGEMENT [J].
BANDO, K ;
PARADIS, IL ;
SIMILO, S ;
KONISHI, H ;
KOMATSU, K ;
ZULLO, TG ;
YOUSEM, SA ;
CLOSE, JM ;
ZEEVI, A ;
DUQUESNOY, RJ ;
MANZETTI, J ;
KEENAN, RJ ;
ARMITAGE, JM ;
HARDESTY, RL ;
GRIFFITH, BP .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (01) :4-14
[30]   ANALYSIS OF TIME-DEPENDENT RISKS FOR INFECTION, REJECTION, AND DEATH AFTER PULMONARY TRANSPLANTATION [J].
BANDO, K ;
PARADIS, IL ;
KOMATSU, K ;
KONISHI, H ;
MATSUSHIMA, M ;
KEENAN, RJ ;
HARDESTY, RL ;
ARMITAGE, JM ;
GRIFFITH, BP .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (01) :49-59